RYTM Covered Call Strategy
RYTM (Rhythm Pharmaceuticals, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company with commercial products, dedicated to the discovery, development, and market launch of therapies addressing rare genetic conditions that cause obesity. Its leading pharmaceutical, IMCIVREE, functions as a powerful agonist of the melanocortin-4 receptor (MC4R). This medication is indicated for treating obesity stemming from deficiencies in pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or the leptin receptor (LEPR), alongside its use in patients with Bardet-Biedl and Alström syndromes. Furthermore, the company is progressing setmelanotide (the active compound in IMCIVREE) through Phase II clinical trials. These studies are evaluating its potential for a broader spectrum of applications, including obesity caused by heterozygous POMC or LEPR deficiencies, steroid receptor coactivator 1 (SRC1) deficiency, SH2B1 deficiency, MC4 receptor deficiency, and obesity associated with Smith-Magenis syndrome, POMC epigenetic disorders, and other MC4R-related conditions. Rhythm Pharmaceuticals holds a collaborative research agreement with the Clinical Registry Investigating Bardet-Biedl Syndrome.
RYTM (Rhythm Pharmaceuticals, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $7.92B, a beta of 1.97 versus the broader market, a 52-week range of 74.5-122.2, average daily share volume of 766K, a public-listing history dating back to 2017, approximately 414 full-time employees. These structural characteristics shape how RYTM stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.97 indicates RYTM has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a covered call on RYTM?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
RYTM snapshot
As of August 14, 2026, spot at $115.39, ATM IV 47.20%, IV rank 13.94%, expected move 13.53%. The covered call on RYTM below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this covered call structure on RYTM specifically: RYTM IV at 47.20% is on the cheap side of its 1-year range, which means a premium-selling RYTM covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 13.53% (roughly $15.61 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated RYTM expiries trade a higher absolute premium for lower per-day decay. Position sizing on RYTM should anchor to the underlying notional of $115.39 per share and to the trader's directional view on RYTM stock.
RYTM covered call setup
The RYTM covered call below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With RYTM at $115.39 on that close, the first option leg uses a $120.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed RYTM chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 RYTM shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $115.39 | long |
| Sell 1 | Call | $120.00 | $5.00 |
RYTM covered call risk and reward
- Net Premium / Debit
- -$11,039.00
- Max Profit (per contract)
- $961.00
- Max Loss (per contract)
- -$11,038.00
- Breakeven(s)
- $110.39
- Risk / Reward Ratio
- 0.087
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
RYTM covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on RYTM. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$11,038.00 |
| $25.52 | -77.9% | -$8,486.77 |
| $51.03 | -55.8% | -$5,935.55 |
| $76.55 | -33.7% | -$3,384.32 |
| $102.06 | -11.6% | -$833.10 |
| $127.57 | +10.6% | +$961.00 |
| $153.08 | +32.7% | +$961.00 |
| $178.60 | +54.8% | +$961.00 |
| $204.11 | +76.9% | +$961.00 |
| $229.62 | +99.0% | +$961.00 |
When traders use covered call on RYTM
Covered calls on RYTM are an income strategy run on existing RYTM stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
RYTM thesis for this covered call
The market-implied 1-standard-deviation range for RYTM extends from approximately $99.78 on the downside to $131.00 on the upside. A RYTM covered call collects premium on an existing long RYTM position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether RYTM will breach that level within the expiration window. Current RYTM IV rank near 13.94% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on RYTM at 47.20%. As a Healthcare name, RYTM options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to RYTM-specific events.
RYTM covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. RYTM positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move RYTM alongside the broader basket even when RYTM-specific fundamentals are unchanged. Short-premium structures like a covered call on RYTM carry tail risk when realized volatility exceeds the implied move; review historical RYTM earnings reactions and macro stress periods before sizing. Always rebuild the position from current RYTM chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on RYTM?
- A covered call on RYTM is the covered call strategy applied to RYTM (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With RYTM stock at $115.39 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed RYTM chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are RYTM covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the RYTM covered call priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 47.20%), the computed maximum profit is $961.00 per contract and the computed maximum loss is -$11,038.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a RYTM covered call?
- The breakeven for the RYTM covered call priced on this page is roughly $110.39 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The RYTM market-implied 1-standard-deviation expected move in the same options snapshot is approximately 13.53%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on RYTM?
- Covered calls on RYTM are an income strategy run on existing RYTM stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current RYTM implied volatility affect this covered call?
- RYTM ATM IV is at 47.20% with IV rank near 13.94%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.